2
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Has the Cure of Breast Cancer with Chemotherapy Become a Reality?

Pages 98-100 | Published online: 11 Jun 2009

References

  • Editorial. Adjuvant systemic therapy for early breast cancer. Lancet 1992; 339(8784)27–28
  • McGuire W L, Clark G M. Prognostic factors and treatment decisions in axillary-node negative breast cancer. N Engl J Med 1992; 326(26)1756–1761
  • Henderson I C. Breast cancer therapy-The price of success. N Engl J Med 1992; 326(26)1774–1775
  • Osborne C K. Prognostic factors for breast cancer: Have they met their promise?. J Clin Oncol 1992; 10(5)679–682
  • McKay M J, Langlands A O. Letter. N Engl J Med 1992; 327(18)1317
  • Haybittle J L. Is breast cancer ever cured?. Rev Endocr Relat Cancer 1983; 14: 13–18
  • Clark G M, Osborne C K. Letter. N Engl J Med 1992; 327(18)1318
  • Henderson I C. Letter. N Engl J Med 1992; 327(18)1318
  • Anderson J, Nielsen J, Christensen L, et al. The significance of the frequency and occurrence of breast cancer for treatment: Essential aspects of new Danish studies of the natural history of breast cancer. Chir Beig 1987; 87: 103–107
  • Hortobagyi G N, Buzdar A U. Ten year survival after chemotherapy for high risk primary and metastatic breast carcinoma. Cancer Invest 1992; 10(1)12, (Abstract 11)
  • Greenspan E M, Erlich R. Inflammatory breast cancer. Preneoplastic and Early Breast Cancer, I Ariel, A Cahan. Williams & Wilkins, Baltimore 1993; 280–292
  • Evans R A. Letter. N Engl J Med 1992; 327(18)1317–1318
  • Adler A, Stein J A, Ben-Efraim S. Immunocompetence, immunosuppression and human breast cancer. Cancer 1980; 45: 2061–2083
  • Mandeville R, Lamoureux G, Legault-Poisson S, et al. Biological markers and breast cancer. Multiparametric study. II. Depressed immunocompetence. Cancer 1982; 50: 1280–1288
  • Greenspan E M. Prior tuberculosis in long-term survivors of breast and ovarian cancer from a New York oncology practice (1954–1974). Mt Sinai J Med 1985; 52: 465–468
  • Greenspan E M. Is BCG an “orphan” drug suffering from chemotherapists' overkill?. Cancer Invest 1986; 4(1)81–92
  • Krown S E, Pinsky C M, Wanebo H J, et al. Immunologic reactivity and prognosis in breast cancer. Cancer 1980; 467: 1746–1752
  • Donegan W L, Kubo K, Shimukzu H, et al. Postsurgical survival of Japanese and American women with cancer of the breast: A cooperative study. 13th International Cancer Congress, Seattle, Washington, 1982, (abstract)
  • Greenspan E M. The Breast Cancer Epidemic in the United States: How 15,000 More Lives Can Be Saved Each Year. Chemotherapy Foundation, New York 1993, Revised

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.